Inari Medical ticks higher after HSR waiting period expires in Stryker deal
Inari Medical ticks higher after HSR waiting period expires in Stryker deal
Penumbra spikes after Stryker- Inari deal
Stryker confirms deal to purchase Inari Medical for $80 a share
Inari Medical soars on report of Stryker talks
Stryker to buy pain therapy developer Vertos Medical
Stryker to acquire care.ai to expand healthcare IT portfolio
148.25BUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8636671013
CUSIP
863667101
Sector
Healthcare
Industry
Medical Devices
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
49.73
PEG Ratio
2.71
Book Value
54.10
Dividend Share
3.24
Dividend Yield
0.86%
Earnings Share
7.77
Wall Street Target Price
423.54
EPS Estimate Current Year
13.51
EPS Estimate Next Year
14.85
EPS Estimate Current Quarter
3.8747
EPS Estimate Next Quarter
2.8565
Most Recent Quarter
-
Revenue TTM
22,595,000,320
Gross Profit TTM
14,545,000,448
EBITDA
6,013,000,192
Profit Margin
13.25%
Return On Assets TTM
7.49%
Return On Equity TTM
15.26%
Revenue Per Share TTM
59.304
Qtly Revenue Growth YOY
10.70%
Diluted Eps TTM
7.77
Qtly Earnings Growth YOY
-52.60%
Trailing PE
49.73
Forward PE
28
Price Sales TTM
6.5256
Price Book MRQ
7.1848
Enterprise Value Revenue
6
Enterprise Value EBITDA
27
89.70
2.00%24.75
0.76%134.15
0.75%25.21
0.68%59.01
0.00%28.84
-1.67%74.00
-0.93%88.67
-0.77%220.22
-0.26%105.28
-0.08%Curated watchlists where SYK is featured.